Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway-Reference-Cited by-同舟云学术

Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway

Published:2019-06-18 Issue:8 Volume:110 Page:2421-2430
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Song Yanfang¹,Lin Qing¹,Cai Zhaolian¹,Hao Taisen²,Zhang Yaohan¹,Zhu Xianjin³^ORCID

Affiliation:

1. Department of Laboratory Medicine Clinical Laboratory The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine Fuzhou China

2. Department of Cancer Biology Beckman Research Institute of City of Hope Duarte USA

3. Department of Clinical Laboratory Fujian Medical University Union Hospital Fuzhou China

Funder

Natural Science Foundation of Fujian Province

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14083

Reference46 articles.

1. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

2. New developments in chronic myeloid leukemia: implications for therapy;Tabarestani S;Iran J Cancer Prev,2016

3. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

4. The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

5. Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity;Journal of Cancer Research and Clinical Oncology;2024-03-26

2. Serum CYR61 as a potential biomarker to improve breast cancer diagnostics;Biomarkers in Medicine;2022-10

3. Diagnostic value of using exosome‑derived cysteine‑rich protein 61 as biomarkers for acute coronary syndrome;Experimental and Therapeutic Medicine;2021-10-12

4. The CCN axis in cancer development and progression;Journal of Cell Communication and Signaling;2021-04-20

5. CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis;Journal of Cell Communication and Signaling;2021-01-11